Amyris Stock Price, News & Analysis (NASDAQ:AMRS)

$3.67 -0.01 (-0.27 %)
(As of 11/22/2017 02:15 AM ET)
Previous Close$3.68
Today's Range$3.57 - $3.74
52-Week Range$1.86 - $14.85
Volume244,500 shs
Average Volume261,808 shs
Market Capitalization$138.02 million
P/E RatioN/A
Dividend YieldN/A
Beta0.07

About Amyris (NASDAQ:AMRS)

Amyris logoAmyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product.


Industry, Sector and Symbol:
  • Industry: Industrial Biotechnology Chemicals
  • Sub-Industry: Oil & Gas Refining & Marketing
  • Sector: Basic Materials
  • Symbol: NASDAQ:AMRS
  • CUSIP: 03236M10
  • Web: amyris.com
Debt:
  • Debt-to-Equity Ratio: -0.76%
  • Current Ratio: 0.65%
  • Quick Ratio: 0.56%
Sales & Book Value:
  • Annual Sales: $77.19 million
  • Price / Sales: 2.05
  • Book Value: ($10.05) per share
  • Price / Book: -0.37
Profitability:
  • Trailing EPS: ($6.24)
  • Net Income: $-97,330,000.00
  • Net Margins: -115.01%
  • Return on Assets: -117.97%
Misc:
  • Employees: 440
  • Outstanding Shares: 43,030,000
 

Frequently Asked Questions for Amyris (NASDAQ:AMRS)

What is Amyris' stock symbol?

Amyris trades on the NASDAQ under the ticker symbol "AMRS."

When did Amyris' stock split? How did Amyris' stock split work?

Amyris's stock reverse split on the morning of Tuesday, June 6th 2017. The 1-15 reverse split was announced on Tuesday, June 6th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 5th 2017. An investor that had 100 shares of Amyris stock prior to the reverse split would have 7 shares after the split.

How were Amyris' earnings last quarter?

Amyris, Inc. (NASDAQ:AMRS) announced its earnings results on Tuesday, November, 14th. The biotechnology company reported ($0.81) EPS for the quarter, missing the Zacks' consensus estimate of ($0.77) by $0.04. The biotechnology company had revenue of $24.20 million for the quarter, compared to analysts' expectations of $36.30 million. The firm's quarterly revenue was down 8.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.07) EPS. View Amyris' Earnings History.

Where is Amyris' stock going? Where will Amyris' stock price be in 2017?

3 analysts have issued twelve-month target prices for Amyris' shares. Their predictions range from $4.00 to $60.00. On average, they expect Amyris' share price to reach $26.33 in the next twelve months. View Analyst Ratings for Amyris.

Who are some of Amyris' key competitors?

Who are Amyris' key executives?

Amyris' management team includes the folowing people:

  • John G. Melo, President, Chief Executive Officer, Director (Age 49)
  • Kathleen Valiasek, Chief Financial Officer
  • Joel Cherry Ph.D., President - Research and Development (Age 54)
  • Eduardo Alvarez, Chief Operating Officer
  • Karen D. Rohde, Chief Human Resources Officer
  • Chris Jaenike, Interim General Counsel
  • Philip Eykerman, Director (Age 49)
  • Christoph Goppelsroeder, Director
  • Frank F. C. Kung Ph.D., Director
  • Christophe Vuillez, Director

Who owns Amyris stock?

Amyris' stock is owned by a number of of retail and institutional investors. Top institutional investors include TEMASEK HOLDINGS (PRIVATE) LTD (13.10%), Tanaka Capital Management Inc. (1.41%), KBC Group NV (0.16%) and Carl Domino Inc (0.15%). Company insiders that own Amyris stock include (Mauritius) Pte Ltd Maxwell, L John Doerr and Patrick Y Yang. View Institutional Ownership Trends for Amyris.

Who bought Amyris stock? Who is buying Amyris stock?

Amyris' stock was purchased by a variety of institutional investors in the last quarter, including Tanaka Capital Management Inc., Carl Domino Inc and KBC Group NV. Company insiders that have bought Amyris stock in the last two years include L John Doerr and Patrick Y Yang. View Insider Buying and Selling for Amyris.

How do I buy Amyris stock?

Shares of Amyris can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Amyris' stock price today?

One share of Amyris stock can currently be purchased for approximately $3.67.

How big of a company is Amyris?

Amyris has a market capitalization of $138.02 million and generates $77.19 million in revenue each year. The biotechnology company earns $-97,330,000.00 in net income (profit) each year or ($6.24) on an earnings per share basis. Amyris employs 440 workers across the globe.

How can I contact Amyris?

Amyris' mailing address is 5885 Hollis St Ste 100, EMERYVILLE, CA 94608-2405, United States. The biotechnology company can be reached via phone at +1-510-4500761 or via email at [email protected]


MarketBeat Community Rating for Amyris (NASDAQ AMRS)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  115 (Vote Outperform)
Underperform Votes:  175 (Vote Underperform)
Total Votes:  290
MarketBeat's community ratings are surveys of what our community members think about Amyris and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Amyris (NASDAQ:AMRS)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 1 Hold Rating, 2 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $26.33 (617.53% upside)

Consensus Price Target History for Amyris (NASDAQ:AMRS)

Price Target History for Amyris (NASDAQ:AMRS)

Analysts' Ratings History for Amyris (NASDAQ:AMRS)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/15/2017HC WainwrightReiterated RatingBuy$15.00N/AView Rating Details
8/17/2017Cowen and CompanySet Price TargetHold$4.00HighView Rating Details
1/11/2017Rodman & RenshawReiterated RatingBuy$60.00N/AView Rating Details
9/28/2016Singular ResearchReiterated RatingBuy$42.00N/AView Rating Details
(Data available from 11/22/2015 forward)

Earnings

Earnings History and Estimates Chart for Amyris (NASDAQ:AMRS)

Earnings by Quarter for Amyris (NASDAQ:AMRS)

Earnings History by Quarter for Amyris (NASDAQ AMRS)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/14/2017Q3 2017($0.77)($0.81)$36.30 million$24.20 millionViewN/AView Earnings Details
8/10/2017Q2 2017($1.06)($1.41)$23.68 million$25.68 millionViewN/AView Earnings Details
5/15/2017Q1 2017($1.35)($1.95)$32.30 million$13.00 millionViewN/AView Earnings Details
3/2/2017Q4 2016($0.75)($1.50)$38.72 million$32.20 millionViewListenView Earnings Details
11/2/2016Q316($0.90)($1.05)$33.61 million$26.50 millionViewN/AView Earnings Details
8/4/2016Q2($1.80)($0.90)$15.23 million$9.60 millionViewN/AView Earnings Details
5/10/2016Q1($1.95)($2.55)$10.39 million$8.80 millionViewListenView Earnings Details
3/9/2016Q4($1.50)($2.40)$32.44 million$9.80 millionViewListenView Earnings Details
11/5/2015Q315($2.55)($3.45)$8.84 million$8.60 millionViewN/AView Earnings Details
8/6/2015Q215($4.65)($7.95)$15.66 million$7.80 millionViewN/AView Earnings Details
5/5/2015Q115($1.50)($6.15)$21.40 million$7.90 millionViewN/AView Earnings Details
2/24/2015Q414($3.00)($12.60)$20.12 million$11.60 millionViewN/AView Earnings Details
11/4/2014Q314($2.10)($4.20)$20.51 million$16.34 millionViewN/AView Earnings Details
8/7/2014Q214($5.55)($5.25)$12.36 million$9.30 millionViewN/AView Earnings Details
5/8/2014Q114($4.80)($5.40)$13.50 million$17.90 millionViewN/AView Earnings Details
2/25/2014Q413($3.60)($3.90)$18.66 millionViewN/AView Earnings Details
10/31/2013Q313($4.50)($4.80)$13.59 million$7.00 millionViewN/AView Earnings Details
8/8/2013Q2 2013($4.80)($5.10)$11.47 million$10.80 millionViewN/AView Earnings Details
4/30/2013Q1 2013($5.85)($5.85)$9.80 million$7.87 millionViewN/AView Earnings Details
2/19/2013Q4 2012($7.65)($7.35)$10.68 million$5.90 millionViewN/AView Earnings Details
11/6/2012Q312($9.45)($3.30)$10.49 million$19.10 millionViewN/AView Earnings Details
7/31/2012($10.35)($9.90)ViewN/AView Earnings Details
5/8/2012($11.40)($28.20)ViewN/AView Earnings Details
11/1/2011($10.65)($14.55)ViewN/AView Earnings Details
8/2/2011($9.45)($14.25)ViewN/AView Earnings Details
5/5/2011($7.50)($11.40)ViewN/AView Earnings Details
2/28/2011($7.35)($7.65)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Amyris (NASDAQ:AMRS)
Current Year EPS Consensus Estimate: $-3.31 EPS
Next Year EPS Consensus Estimate: $-1.76 EPS

Dividends

Dividend History for Amyris (NASDAQ:AMRS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Amyris (NASDAQ AMRS)

Insider Ownership Percentage: 11.30%
Institutional Ownership Percentage: 17.36%
Insider Trades by Quarter for Amyris (NASDAQ:AMRS)
Institutional Ownership by Quarter for Amyris (NASDAQ:AMRS)

Insider Trades by Quarter for Amyris (NASDAQ AMRS)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/19/2017Patrick Y YangDirectorBuy300,000$0.29$87,000.00View SEC Filing  
4/20/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell652,513$0.55$358,882.15View SEC Filing  
4/18/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell1,636,930$0.65$1,064,004.50View SEC Filing  
3/30/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell184,535$0.51$94,112.85View SEC Filing  
3/29/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell417,990$0.51$213,174.90View SEC Filing  
3/27/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell129,059$0.48$61,948.32View SEC Filing  
3/23/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell165,428$0.48$79,405.44View SEC Filing  
3/21/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell223,073$0.48$107,075.04View SEC Filing  
3/20/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell88,382$0.49$43,307.18View SEC Filing  
3/17/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell339,908$0.49$166,554.92View SEC Filing  
3/15/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell270,374$0.46$124,372.04View SEC Filing  
3/13/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell346,429$0.50$173,214.50View SEC Filing  
3/9/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell520,925$0.46$239,625.50View SEC Filing  
3/7/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell852,224$0.45$383,500.80View SEC Filing  
3/3/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell868,589$0.49$425,608.61View SEC Filing  
3/1/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell377,823$0.51$192,689.73View SEC Filing  
2/27/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell287,706$0.52$149,607.12View SEC Filing  
2/23/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell529,747$0.53$280,765.91View SEC Filing  
2/21/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell287,528$0.56$161,015.68View SEC Filing  
2/16/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell390,918$0.54$211,095.72View SEC Filing  
2/10/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell429,198$0.51$218,890.98View SEC Filing  
2/8/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell288,765$0.50$144,382.50View SEC Filing  
1/12/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell29,502$0.81$23,896.62View SEC Filing  
1/11/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell451,806$0.81$365,962.86View SEC Filing  
1/9/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell1,072,847$0.81$869,006.07View SEC Filing  
12/14/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell87,291$0.80$69,832.80View SEC Filing  
12/12/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell54,286$0.80$43,428.80View SEC Filing  
12/8/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell285,623$0.81$231,354.63View SEC Filing  
12/6/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell578,550$0.81$468,625.50View SEC Filing  
12/2/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell556,296$0.84$467,288.64View SEC Filing  
11/22/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell77,383$0.80$61,906.40View SEC Filing  
11/17/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell509,779$0.81$412,920.99View SEC Filing  
11/15/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell648,342$0.81$525,157.02View SEC Filing  
11/11/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell427,904$0.81$346,602.24View SEC Filing  
11/8/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell333,811$0.82$273,725.02View SEC Filing  
11/4/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell2,611,233$0.89$2,323,997.37View SEC Filing  
10/17/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell2,300,000$0.83$1,909,000.00View SEC Filing  
6/14/2016L John DoerrDirectorBuy200,577$1.04$208,600.08View SEC Filing  
10/14/2015Energies Nouvelles Activ TotalDirectorSell80,052$2.36$188,922.72View SEC Filing  
6/5/2015John MeloCEOSell61,276$2.00$122,552.00View SEC Filing  
5/12/2015John MeloCEOSell65,575$2.08$136,396.00View SEC Filing  
5/15/2014L John DoerrDirectorBuy172,186$3.02$520,001.72View SEC Filing  
5/24/2013John MeloCEOSell24,402$2.85$69,545.70View SEC Filing  
3/27/2013Thani Sheikh Abdullah Bin K AlDirectorBuy1,533,742$3.26$4,999,998.92View SEC Filing  
12/24/2012Thani Sheikh Abdullah Bin K AlDirectorBuy3,355,704$2.98$9,999,997.92View SEC Filing  
8/31/2012John MeloCEOSell668,730$3.70$2,474,301.00View SEC Filing  
8/31/2012L John DoerrDirectorBuy270,270$3.70$999,999.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Amyris (NASDAQ AMRS)

Source:
DateHeadline
Amyris Schedules Teleconference to Provide Additional Details on Expanded Strategic Alliance with Royal DSM for ... - NasdaqAmyris Schedules Teleconference to Provide Additional Details on Expanded Strategic Alliance with Royal DSM for ... - Nasdaq
www.nasdaq.com - November 21 at 9:26 PM
Amyris Schedules Teleconference to Provide Additional Details on Expanded Strategic Alliance with Royal DSM for Tuesday, November 28, 2017Amyris Schedules Teleconference to Provide Additional Details on Expanded Strategic Alliance with Royal DSM for Tuesday, November 28, 2017
finance.yahoo.com - November 21 at 4:24 PM
HC Wainwright Reaffirms "Buy" Rating for Amyris, Inc. (AMRS)HC Wainwright Reaffirms "Buy" Rating for Amyris, Inc. (AMRS)
www.americanbankingnews.com - November 19 at 5:38 PM
DSM Expands Strategic Alliance with Amyris and Acquires Brazilian Production Facility from Amyris - GlobeNewswire (press release)DSM Expands Strategic Alliance with Amyris and Acquires Brazilian Production Facility from Amyris - GlobeNewswire (press release)
globenewswire.com - November 18 at 8:52 PM
DSM Expands Strategic Alliance with Amyris and Acquires Brazilian Production Facility from AmyrisDSM Expands Strategic Alliance with Amyris and Acquires Brazilian Production Facility from Amyris
finance.yahoo.com - November 17 at 10:44 AM
Edited Transcript of AMRS earnings conference call or presentation 14-Nov-17 9:30pm GMTEdited Transcript of AMRS earnings conference call or presentation 14-Nov-17 9:30pm GMT
finance.yahoo.com - November 16 at 11:13 AM
Amyris reports 3Q lossAmyris reports 3Q loss
finance.yahoo.com - November 16 at 11:13 AM
Amyris, Inc. (AMRS) Releases Quarterly  Earnings Results, Misses Expectations By $0.04 EPSAmyris, Inc. (AMRS) Releases Quarterly Earnings Results, Misses Expectations By $0.04 EPS
www.americanbankingnews.com - November 15 at 10:34 AM
Amyris Reports Another Strong Quarter of Product Sales Growth and Expects Strong Finish for 2017 - GlobeNewswire (press release)Amyris Reports Another Strong Quarter of Product Sales Growth and Expects Strong Finish for 2017 - GlobeNewswire (press release)
globenewswire.com - November 14 at 4:21 PM
Amyris, Inc. to Host Earnings CallAmyris, Inc. to Host Earnings Call
finance.yahoo.com - November 14 at 4:21 PM
Amyris Reports Another Strong Quarter of Product Sales Growth and Expects Strong Finish for 2017Amyris Reports Another Strong Quarter of Product Sales Growth and Expects Strong Finish for 2017
finance.yahoo.com - November 14 at 4:21 PM
Carl Domino Inc Buys DowDuPont Inc, Bank of America Corporation, CenturyLink Inc, Sells Paychex ...Carl Domino Inc Buys DowDuPont Inc, Bank of America Corporation, CenturyLink Inc, Sells Paychex ...
www.nasdaq.com - November 8 at 8:34 PM
Should You Worry About Amyris Inc’s (AMRS) CEO Pay?Should You Worry About Amyris Inc’s (AMRS) CEO Pay?
finance.yahoo.com - November 8 at 3:27 PM
Amyris Reschedules Third Quarter 2017 Financial Results Teleconference for Tuesday, November 14, 2017 - GlobeNewswire (press release)Amyris Reschedules Third Quarter 2017 Financial Results Teleconference for Tuesday, November 14, 2017 - GlobeNewswire (press release)
globenewswire.com - November 8 at 6:15 AM
Amyris Reschedules Third Quarter 2017 Financial Results Teleconference for Tuesday, November 14, 2017Amyris Reschedules Third Quarter 2017 Financial Results Teleconference for Tuesday, November 14, 2017
finance.yahoo.com - November 7 at 10:38 PM
Amyris, Inc. (AMRS) Set to Announce Quarterly Earnings on WednesdayAmyris, Inc. (AMRS) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - November 1 at 8:08 PM
Interested In The Energy Industry? Take A Look At Amyris Inc (AMRS)Interested In The Energy Industry? Take A Look At Amyris Inc (AMRS)
finance.yahoo.com - October 31 at 5:05 PM
ETFs with exposure to Amyris, Inc. : October 27, 2017ETFs with exposure to Amyris, Inc. : October 27, 2017
finance.yahoo.com - October 27 at 6:00 PM
H&R Makes Equity Investment in Novvi and its High-Performance Renewable Base Oil TechnologyH&R Makes Equity Investment in Novvi and its High-Performance Renewable Base Oil Technology
finance.yahoo.com - October 26 at 10:46 AM
Amyris to Announce Third Quarter 2017 Financial Results on Wednesday, November 8, 2017Amyris to Announce Third Quarter 2017 Financial Results on Wednesday, November 8, 2017
finance.yahoo.com - October 25 at 4:55 PM
Amyris, Inc. (AMRS) Set to Announce Quarterly Earnings on TuesdayAmyris, Inc. (AMRS) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - October 24 at 9:58 AM
Amyris, Inc. (AMRS) Downgraded to "Hold" at Zacks Investment ResearchAmyris, Inc. (AMRS) Downgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - October 23 at 8:10 PM
ETFs with exposure to Amyris, Inc. : October 12, 2017ETFs with exposure to Amyris, Inc. : October 12, 2017
finance.yahoo.com - October 12 at 4:38 PM
Amyris (AMRS) Names Eduardo Alvarez COOAmyris (AMRS) Names Eduardo Alvarez COO
www.streetinsider.com - October 9 at 9:57 PM
Amyris (AMRS) Names Eduardo Alvarez COO - StreetInsider.comAmyris (AMRS) Names Eduardo Alvarez COO - StreetInsider.com
www.streetinsider.com - October 9 at 4:52 PM
Amyris Appoints Chief Operating Officer to Support Continued Strong GrowthAmyris Appoints Chief Operating Officer to Support Continued Strong Growth
feeds.benzinga.com - October 9 at 8:52 AM
Amyris, Inc. (AMRS) Lifted to "Buy" at Zacks Investment ResearchAmyris, Inc. (AMRS) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - October 4 at 8:32 PM
ETFs with exposure to Amyris, Inc. : September 28, 2017ETFs with exposure to Amyris, Inc. : September 28, 2017
finance.yahoo.com - October 2 at 3:39 PM
How Does Amyris Inc (AMRS) Affect Your Portfolio Returns?How Does Amyris Inc (AMRS) Affect Your Portfolio Returns?
finance.yahoo.com - October 2 at 3:39 PM
Amyris (AMRS) "Buy" Rating Reaffirmed at HC WainwrightAmyris' (AMRS) "Buy" Rating Reaffirmed at HC Wainwright
www.americanbankingnews.com - September 26 at 1:16 PM
ETFs with exposure to Amyris, Inc. : September 13, 2017ETFs with exposure to Amyris, Inc. : September 13, 2017
finance.yahoo.com - September 13 at 10:05 PM
Amyris (AMRS) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - SlideshowAmyris (AMRS) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow
seekingalpha.com - September 12 at 4:05 PM
Amyris, Inc. (AMRS) Given Consensus Rating of "Hold" by AnalystsAmyris, Inc. (AMRS) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - September 11 at 2:22 AM
Amyris to Present at Rodman & Renshaw 19th Annual Global Investment Conference on September 11, 2017Amyris to Present at Rodman & Renshaw 19th Annual Global Investment Conference on September 11, 2017
finance.yahoo.com - September 6 at 3:45 PM
ETFs with exposure to Amyris, Inc. : August 31, 2017ETFs with exposure to Amyris, Inc. : August 31, 2017
finance.yahoo.com - September 1 at 1:14 AM
Amyris, Inc. (AMRS) Short Interest Up 43.2% in AugustAmyris, Inc. (AMRS) Short Interest Up 43.2% in August
www.americanbankingnews.com - August 28 at 1:20 AM
Amyris, Inc. :AMRS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017Amyris, Inc. :AMRS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 25 at 5:26 PM
Amyris, Inc. (AMRS) Given a $4.00 Price Target by Cowen and Company AnalystsAmyris, Inc. (AMRS) Given a $4.00 Price Target by Cowen and Company Analysts
www.americanbankingnews.com - August 20 at 8:16 PM
Amyris, Inc. (AMRS) Receives Average Recommendation of "Hold" from AnalystsAmyris, Inc. (AMRS) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - August 17 at 2:32 AM
HC Wainwright Analysts Give Amyris, Inc. (NASDAQ:AMRS) a $15.00 Price TargetHC Wainwright Analysts Give Amyris, Inc. (NASDAQ:AMRS) a $15.00 Price Target
www.americanbankingnews.com - August 13 at 3:32 PM
Edited Transcript of AMRS earnings conference call or presentation 10-Aug-17 8:30pm GMTEdited Transcript of AMRS earnings conference call or presentation 10-Aug-17 8:30pm GMT
finance.yahoo.com - August 12 at 2:26 AM
Amyris, Inc. (AMRS) Posts  Earnings Results, Misses Estimates By $0.30 EPSAmyris, Inc. (AMRS) Posts Earnings Results, Misses Estimates By $0.30 EPS
www.americanbankingnews.com - August 10 at 9:35 PM
Amyris Delivers Another Strong Quarter with Revenue of $25.7 Million and Product Sales Increase of 159% over 2nd Quarter of 2016Amyris Delivers Another Strong Quarter with Revenue of $25.7 Million and Product Sales Increase of 159% over 2nd Quarter of 2016
finance.yahoo.com - August 10 at 5:15 PM
Amyris posts 2Q profitAmyris posts 2Q profit
finance.yahoo.com - August 10 at 5:15 PM
Amyris EPS of -$1.36Amyris EPS of -$1.36
seekingalpha.com - August 10 at 4:49 PM
Amyris Announces Closing of $50 Million in Second Tranche Equity Financing – Fully Capitalized with Very Strong Business MomentumAmyris Announces Closing of $50 Million in Second Tranche Equity Financing – Fully Capitalized with Very Strong Business Momentum
finance.yahoo.com - August 9 at 4:02 PM
18 Biggest Mid-Day Losers For Monday | Benzinga - Benzinga18 Biggest Mid-Day Losers For Monday | Benzinga - Benzinga
www.benzinga.com - August 8 at 2:48 AM
Amyris, Inc. (AMRS) Set to Announce Quarterly Earnings on ThursdayAmyris, Inc. (AMRS) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - August 3 at 8:10 PM
Amyris to Announce Second Quarter 2017 Financial Results on Thursday, August 10, 2017Amyris to Announce Second Quarter 2017 Financial Results on Thursday, August 10, 2017
finance.yahoo.com - August 1 at 4:49 PM
Amyris Biossance Launches in SEPHORA Canada Stores - GlobeNewswire (press release)Amyris Biossance Launches in SEPHORA Canada Stores - GlobeNewswire (press release)
globenewswire.com - July 26 at 4:24 PM

Social Media

Financials

Chart

Amyris (NASDAQ AMRS) Chart for Wednesday, November, 22, 2017
Loading chart…

This page was last updated on 11/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.